Table 6 Dimension 5: Crude and adjusted associations between patient characteristics and patients' evaluation of aspects of the accessibility.
100% positive assessments 1 | 0–49% positive assessments 2 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
Prev.(%) | PR | Adj. PR | 95% CI | Prev.(%) | PR | Adj.PR | 95% CI | ||
Gender | |||||||||
(N = 25560) | Female | 29.1 | 1 | 1 | 34.0 | 1 | 1 | ||
Male | 32.3 | 1.11 | 0.97 | 0.93 – 1.02 | 30.7 | 0.90 | 0.99 | 0.94 – 1.03 | |
Age (years) | |||||||||
(N = 25560) | 18–24 | 17.8 | 1 | 1 | 39.5 | 1 | 1 | ||
25–29 | 19.7 | 1.11 | 1.09 | 0.94 – 1.26 | 40.7 | 1.03 | 1.04 | 0.96 – 1.13 | |
30–34 | 21.0 | 1.18 | 1.19 | 1.03 – 1.37 | 39.4 | 1.00 | 0.98 | 0.90 – 1.07 | |
35–39 | 21.5 | 1.21 | 1.25 | 1.09 – 1.44 | 40.0 | 1.01 | 0.97 | 0.89 – 1.06 | |
40–44 | 23.6 | 1.32 | 1.42 | 1.23 – 1.64 | 39.5 | 1.00 | 0.93 | 0.85 – 1.02 | |
45–49 | 26.5 | 1.49 | 1.62 | 1.41 – 1.87 | 35.7 | 0.90 | 0.83 | 0.76 – 0.91 | |
50–54 | 27.9 | 1.57 | 1.75 | 1.52 – 2.01 | 35.0 | 0.88 | 0.80 | 0.73 – 0.88 | |
55–59 | 34.3 | 1.92 | 2.17 | 1.90 – 2.48 | 29.4 | 0.74 | 0.67 | 0.61 – 0.75 | |
60–64 | 38.5 | 2.16 | 2.44 | 2.12 – 2.80 | 26.5 | 0.67 | 0.60 | 0.54 – 0.67 | |
65–69 | 42.6 | 2.39 | 2.72 | 2.37 – 3.12 | 22.9 | 0.58 | 0.53 | 0.46 – 0.59 | |
70–74 | 46.7 | 2.62 | 2.99 | 2.61 – 3.42 | 20.8 | 0.53 | 0.48 | 0.42 – 0.54 | |
75–79 | 46.5 | 2.61 | 2.97 | 2.60 – 3.39 | 20.2 | 0.51 | 0.46 | 0.40 – 0.53 | |
80+ | 45.7 | 2.56 | 2.96 | 2.57 – 3.41 | 22.4 | 0.57 | 0.51 | 0.45 – 0.57 | |
Further education (years) | |||||||||
(N = 24385) | None | 32.6 | 1 | 1 | 31.7 | 1 | 1 | ||
Less than 2 | 30.6 | 0.90 | 1.08 | 0.99 – 1.16 | 34.7 | 1.09 | 1.00 | 0.93 – 1.08 | |
2–4 | 28.6 | 0.76 | 1.00 | 0.95 – 1.06 | 34.1 | 1.08 | 0.98 | 0.93 – 1.03 | |
5 or more | 29.3 | 0.66 | 1.02 | 0.94 – 1.10 | 32.1 | 1.01 | 0.93 | 0.86 – 1.01 | |
Undergoing education or other | 32.2 | 0.80 | 1.16 | 1.06 – 1.27 | 28.8 | 0.91 | 0.83 | 0.75 – 0.91 | |
Frequency of attendance (times per year) | |||||||||
(N = 25560) | 0–1 | 28.3 | 1 | 1 | 35.9 | 1 | 1 | ||
2–3 | 26.9 | 0.95 | 0.99 | 0.92 – 1.07 | 37.0 | 1.03 | 1.00 | 0.94 – 1.06 | |
4–5 | 29.8 | 1.05 | 1.06 | 0.98 – 1.14 | 33.5 | 0.93 | 0.92 | 0.86 – 0.98 | |
6–7 | 31.4 | 1.11 | 1.14 | 1.04 – 1.24 | 30.0 | 0.84 | 0.81 | 0.75 – 0.87 | |
8–9 | 33.9 | 1.20 | 1.21 | 1.11 – 1.33 | 28.5 | 0.79 | 0.77 | 0.70 – 0.84 | |
10+ | 35.3 | 1.25 | 1.30 | 1.20 – 1.42 | 26.8 | 0.75 | 0.69 | 0.64 – 0.75 | |
Duration of listing (years) | |||||||||
(N = 17001) | Less than 1 | 24.6 | 1 | 1 | 36.8 | 1 | 1 | ||
1–2 | 25.9 | 1.05 | 0.99 | 0.87 – 1.12 | 36.1 | 0.98 | 1.03 | 0.94 – 1.12 | |
3–7 | 27.2 | 1.11 | 1.00 | 0.89 – 1.12 | 34.7 | 0.94 | 1.01 | 0.93 – 1.09 | |
8–12 | 31.8 | 1.29 | 1.12 | 0.98 – 1.28 | 31.6 | 0.86 | 0.95 | 0.86 – 1.05 | |
13+ | 38.0 | 1.55 | 1.29 | 1.13 – 1.48 | 26.5 | 0.72 | 0.82 | 0.73 – 0.92 | |
Self-rated health | |||||||||
(N = 25560) | Excellent | 30.6 | 1 | 1 | 30.1 | 1 | 1 | ||
Very good | 28.6 | 0.93 | 0.83 | 0.78 – 0.89 | 33.6 | 1.11 | 1.19 | 1.11 – 1.28 | |
Good | 30.6 | 1.00 | 0.68 | 0.64 – 0.73 | 33.4 | 1.11 | 1.44 | 1.34 – 1.54 | |
Fair | 30.7 | 1.00 | 0.60 | 0.55 – 0.65 | 33.3 | 1.11 | 1.64 | 1.51 – 1.78 | |
Poor | 33.0 | 1.08 | 0.62 | 0.56 – 0.70 | 29.2 | 0.97 | 1.49 | 1.31 – 1.69 | |
Chronic condition | |||||||||
(N = 25197) | No | 27.6 | 1 | 1 | 35.2 | 1 | 1 | ||
Yes-KRTC | 36.6 | 1.33 | 1.04 | 0.98 – 1.10 | 27.9 | 0.79 | 0.97 | 0.91 – 1.03 | |
Yes-other or multiple | 30.5 | 1.10 | 1.01 | 0.96 – 1.06 | 32.1 | 0.91 | 0.95 | 0.91 – 1.00 | |
Chronic condition | |||||||||
(N = 17208) | None | 27.6 | 1 | 1 | 35.2 | 1 | 1 | ||
K – Cardiovascular | 37.7 | 1.37 | 1.01 | 0.94 – 1.09 | 26.1 | 0.74 | 0.96 | 0.86 – 1.06 | |
R – Respiratory | 32.3 | 1.17 | 1.04 | 0.95 – 1.15 | 31.8 | 0.90 | 0.99 | 0.90 – 1.09 | |
T – Endocrine | 37.0 | 1.34 | 1.08 | 0.99 – 1.17 | 28.9 | 0.82 | 0.98 | 0.88 – 1.09 | |
C – Cancer | 42.7 | 1.55 | 1.15 | 1.01 – 1.32 | 22.3 | 0.63 | 0.78 | 0.61 – 0.98 | |